Roval Pharma SPRL
Roval Pharma reported total assets of 784,432 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Sep 2026).
The score of Roval Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +36 % Total assets +13 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Roval Pharma's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 77,986 € | ||||
| Equity | 709,849 € | ||||
| Cash | 10,669 € | ||||
| EBITDA | 106,106 € | ||||
| Total assets | 784,432 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Sep 2026
- Year ended 31 Dec 2024filed on 17 Aug 2025
- Year ended 31 Dec 2023filed on 18 Nov 2024
- Year ended 31 Dec 2022filed on 29 Sep 2023
- Year ended 31 Dec 2021filed on 03 Jun 2022
Roval Pharma's financial analysis
- Solvency90.5%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Roval Pharma
Roval Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0553.481.307
- VAT number
- BE0553481307
- Peppol
- Registered · 0208:0553481307 · as of 10 Nov 2026
- Legal form
- SPRL
- Incorporated
- 28 May 2014
- Registered office
- 1547 Bever
- Latest accounts
- 2025 · filed on 30 Sep 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Roval Pharma (SPRL) has been based in Bever since 2014, active in: business and other management consultancy activities. For 2025, it reports a net profit of 77,986 € and equity of 709,849 €; its revenue is not published. Its solvency stands at 90.5%, above the median of its sector (58.4%).
Companies similar to Roval Pharma
Companies in the same business, of comparable size and area, outside its group.
- Wigilon Business and other management consultancy activities Londerzeel · balance sheet 784,903 €
- Eosalis Business and other management consultancy activities Bierbeek · balance sheet 744,341 €
- LUC Switten Business and other management consultancy activities Zonhoven · balance sheet 780,301 €
- Chess IN Health Business and other management consultancy activities Bonheiden · balance sheet 778,666 €
- Framtid Business and other management consultancy activities Dilbeek · balance sheet 777,079 €
- ANJI Business and other management consultancy activities Mechelen · balance sheet 775,638 €
- Delrue Steel Invest Business and other management consultancy activities Mouscron · balance sheet 895,182 €
- ChaTho Projects Business and other management consultancy activities Beveren-Kruibeke-Zwijndrecht · balance sheet 796,778 €
Frequently asked questions about Roval Pharma
What is the revenue of Roval Pharma?
Roval Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Roval Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0553481307 for Roval Pharma, if the company is VAT-registered. Its company number (CBE) is 0553.481.307.
Where is the registered office of Roval Pharma?
According to the CBE register, the registered office of Roval Pharma is in 1547 Bever.
What is the equity of Roval Pharma?
At the close of the 2025 financial year, the equity of Roval Pharma amounts to 709,849 €, a solvency of 90.5% of total assets.
Who manages Roval Pharma?
The register lists 1 active mandates at Roval Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Roval Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →